Work

Supplementary Figure S7 from Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S7. Graphic representation of inflammatory pathways activated by checkpoint inhibitor (CPI) therapy in selected immune-related cutaneous adverse events (ircAEs) and associated targets for cytokine-directed therapies.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4400215239
Cites:
Cited by:
Related to: 10